Skip to content

Prognosis Prediction Model for Neuromyelitis Optica Spectrum Disorders

Prognosis Prediction Model for Neuromyelitis Optica Spectrum Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016241
Enrollment
Unknown
Registered
2018-05-21
Start date
2018-06-15
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromyelitis optica spectrum disorders

Interventions

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients fulfilling the 2015 diagnostic criteria for NMOSD, published by the International Panel of NMO Diagnosis (IPND); 2. patients previously diagnosed with NMO orNMOSD andwith EDSS score less than 3.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. severe liver and kidney function or other organ dysfunction; 3. lost to follow-up because of loss of contact or poor compliance; incomplete medical records; 4. inability to complete the follow-up because of disturbance in consciousness or severe speech disorders.

Design outcomes

Primary

MeasureTime frame
EDSS=6;

Secondary

MeasureTime frame
Death;relapse;

Countries

China

Contacts

Public ContactHongyu Zhou

West China Hospital, Sichuan University

924339836@qq.com+86 18980601675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026